Cynata Therapeutics secures funds to progress stem cell technology – Proactive Investors Australia
Proactive Investors Australia |
Cynata Therapeutics secures funds to progress stem cell technology
Proactive Investors Australia The company intends to use the proceeds of the placement and the FUJIFILM investment to accelerate the development of its Cymerus therapeutic mesenchymal stem cell (MSC) technology. Cynata is developing cellular therapies to treat respiratory disease, … |
